Summit Securities Group’s Qiagen QGEN Stock Holding History

Summit Securities Group’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-283	Closed	-$1.28M	–	472
2020 Q2	$1.28M	Buy	283 +165	+140%	+$7.38K	0.16%	125
2020 Q1	$520K	Buy	+118	New	+$4.61K	0.09%	163

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Summit Securities Group's QGEN Position: Q2 2026 in Review

Summit Securities Group sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 5,000 shares — an estimated $200K sold.

Summit Securities Group first reported a position in QGEN in Q2 2020 and held it in 7 quarters. The position peaked at $7.48M in Q2 2023. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Summit Securities Group reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Summit Securities Group sold 5,000 Qiagen shares in Q2 2026, an estimated $200K.
Summit Securities Group first reported a position in Qiagen in Q2 2020 and held it in 7 quarters.
Summit Securities Group's Qiagen position peaked at $7.48M in Q2 2023.
337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.